Symbol
| MUL1
| contributors: SGE/npt - updated : 13-06-2019
|
HGNC name
| mitochondrial E3 ubiquitin ligase 1
|
HGNC id
| 25762
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
|  
|  
|
in head and neck cancer (HNC) | |
Susceptibility
|
to Parkinson disease (PD) |
Variant & Polymorphism
SNP
| rs529974 in MUL1 gene was significantly associated with the risk of PD |
|
|
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | head and neck | | |
regulation of FOXO3-MUL1-AKT1 axis can be a novel strategy for the treatment of head and neck cancer (HNC) with cisplatin (CDDP) | cancer | head and neck | | |
regulation of the MUL1-HSPA5 axis can be a novel strategy for the treatment of HNC |
| | | |